Amanote Research
Register
Sign In
Human Medicines European Public Assessment Report (EPAR): Pregabalin Accord, Pregabalin, Anxiety Disorders,Epilepsy, Date of Authorisation: 28/08/2015, Revision: 6, Status: Authorised
Case Medical Research
doi 10.31525/cmr-1250c33
Full Text
Open PDF
Abstract
Available in
full text
Date
May 10, 2019
Authors
Unknown
Publisher
Case Journals
Related search
Human Medicines European Public Assessment Report (EPAR): Pregabalin Pfizer, Pregabalin, Anxiety Disorders,Epilepsy, Date of Authorisation: 10/04/2014, Revision: 13, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Farydak, Panobinostat, Multiple Myeloma, Date of Authorisation: 28/08/2015, Revision: 6, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Lenvima, Lenvatinib, Thyroid Neoplasms, Date of Authorisation: 28/05/2015, Revision: 6, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Odomzo, Sonidegib, Carcinoma, Basal Cell, Date of Authorisation: 14/08/2015, Revision: 6, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Intelence, Etravirine, HIV Infections, Date of Authorisation: 28/08/2008, Revision: 23, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Aripiprazole Accord, Aripiprazole, Schizophrenia,Bipolar Disorder, Date of Authorisation: 15/11/2015, Revision: 6, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Briviact (In Italy: Nubriveo), Brivaracetam, Epilepsy, Date of Authorisation: 13/01/2016, Revision: 6, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Ivabradine Anpharm, Ivabradine, Angina Pectoris,Heart Failure, Date of Authorisation: 08/09/2015, Revision: 4, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Levetiracetam Sun, Levetiracetam, Epilepsy, Date of Authorisation: 14/12/2011, Revision: 11, Status: Authorised
Case Medical Research
